Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin. 2024;74(3):229–263

Article  PubMed  Google Scholar 

Vogel A, Meyer T, Sapisochin G, Salem R, Saborowski A. Hepatocellular carcinoma [J]. Lancet. 2022;400(10360):1345–1362

Article  CAS  PubMed  Google Scholar 

Lau G, Obi S, Zhou J, Tateishi R, Qin S, Zhao H, et al. APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024 [J]. Hepatol Int. 2024;18(6):1661–1683

Article  PubMed  Google Scholar 

Wen T, Jin C, Facciorusso A, Donadon M, Han HS, Mao Y, et al. Multidisciplinary management of recurrent and metastatic hepatocellular carcinoma after resection: an international expert consensus [J]. Hepatobiliary Surg Nutr. 2018;7(5):353–371

Article  PubMed  PubMed Central  Google Scholar 

Yoon YI, Song GW, Lee S, Moon D, Hwang S, Kang WH, et al. Salvage living donor liver transplantation versus repeat liver resection for patients with recurrent hepatocellular carcinoma and Child-Pugh class A liver cirrhosis: A propensity score-matched comparison [J]. Am J Transplant. 2022;22(1):165–176

Article  PubMed  Google Scholar 

Sanghera C, Teh JJ, Pinato DJ. The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma [J]. Liver Int. 2019;39(11):2008–2023

Article  PubMed  Google Scholar 

Gavriilidis P, Pawlik TM. Inflammatory indicators such as systemic immune inflammation index (SIII), systemic inflammatory response index (SIRI), neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic factors of curative hepatic resections for hepatocellular carcinoma [J]. Hepatobiliary Surg Nutr. 2024;13(3):509–511

Article  PubMed  PubMed Central  Google Scholar 

Geh D, Leslie J, Rumney R, Reeves HL, Bird TG, Mann DA. Neutrophils as potential therapeutic targets in hepatocellular carcinoma [J]. Nat Rev Gastroenterol Hepatol. 2022;19(4):257–273

Article  CAS  PubMed  Google Scholar 

Lu C, Rong D, Zhang B, Zheng W, Wang X, Chen Z, et al. Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities [J]. Mol Cancer. 2019;18(1):130

Article  PubMed  PubMed Central  Google Scholar 

Papayannopoulos V. Neutrophil extracellular traps in immunity and disease [J]. Nat Rev Immunol. 2018;18(2):134–147

Article  CAS  PubMed  Google Scholar 

Chen H, Zhou XH, Li JR, Zheng TH, Yao FB, Gao B, et al. Neutrophils: Driving inflammation during the development of hepatocellular carcinoma [J]. Cancer Lett. 2021;522:22–31

Article  CAS  PubMed  Google Scholar 

Minagawa M, Makuuchi M, Takayama T, Kokudo N. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma [J]. Ann Surg. 2003;238(5):703–710

Article  PubMed  PubMed Central  Google Scholar 

SHELAT V G, SERIN K, SAMIM M, BESSELINK M G, AL SAATI H, GIOIA P D, et al. Outcomes of repeat laparoscopic liver resection compared to the primary resection [J]. World Journal of Surgery, 2014; 38(12): 3175–80.

Zandavi SM, Kim C, Goodwin T, Thilakanathan C, Bostanara M, Akon AC, et al. AI-powered prediction of HCC recurrence after surgical resection: Personalised intervention opportunities using patient-specific risk factors [J]. Liver Int. 2024;44(10):2724–2737

Article  PubMed  Google Scholar 

Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival [J]. Hepatology. 2001;33(6):1394–1403

Article  CAS  PubMed  Google Scholar 

Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience [J]. Ann Surg. 2009;250(2):187–196

Article  PubMed  Google Scholar 

ALBRENGUES J, SHIELDS M A, NG D, PARK C G, AMBRICO A, POINDEXTER M E, et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice [J]. Science, 2018; 361(6409).

ZHOU J, SUN H, WANG Z, CONG W, ZENG M, ZHOU W, et al. Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition) [J]. Liver Cancer, 2023; 12(5): 405–44.

Zhang X, Li C, Wen T, Peng W, Yan L, Yang J. Treatment for intrahepatic recurrence after curative resection of hepatocellular carcinoma: Salvage liver transplantation or re-resection/radiofrequency ablation? A Retrospective Cohort Study [J]. Int J Surg. 2017;46:178–185

Article  PubMed  Google Scholar 

Kostakis ID, Machairas N, Prodromidou A, Stamopoulos P, Garoufalia Z, Fouzas I, et al. Comparison Between Salvage Liver Transplantation and Repeat Liver Resection for Recurrent Hepatocellular Carcinoma: A Systematic Review and Meta-analysis [J]. Transplant Proc. 2019;51(2):433–436

Article  CAS  PubMed  Google Scholar 

Fan J, Yang GS, Fu ZR, Peng ZH, Xia Q, Peng CH, et al. Liver transplantation outcomes in 1,078 hepatocellular carcinoma patients: a multi-center experience in Shanghai, China [J]. J Cancer Res Clin Oncol. 2009;135(10):1403–1412

Article  PubMed  Google Scholar 

Xu X, Lu D, Ling Q, Wei X, Wu J, Zhou L, et al. Liver transplantation for hepatocellular carcinoma beyond the Milan criteria [J]. Gut. 2016;65(6):1035–1041

Article  CAS  PubMed  Google Scholar 

Duan M, Hao J, Cui S, Worthley DL, Zhang S, Wang Z, et al. Diverse modes of clonal evolution in HBV-related hepatocellular carcinoma revealed by single-cell genome sequencing [J]. Cell Res. 2018;28(3):359–373

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen J, Li H, Zhuo J, Lin Z, Hu Z, He C, et al. Impact of immunosuppressants on tumor pulmonary metastasis: new insight into transplantation for hepatocellular carcinoma [J]. Cancer Biol Med. 2024;21(11):1033–1049

Article  PubMed  PubMed Central  Google Scholar 

Qi LN, Ma L, Wu FX, Chen YY, Xu JX, Peng YC, et al. Clinical implications and biological features of a novel postoperative recurrent HCC classification: A multi-centre study [J]. Liver Int. 2022;42(10):2283–2298

Article  CAS  PubMed  Google Scholar 

Qu WF, Tian MX, Lu HW, Zhou YF, Liu WR, Tang Z, et al. Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation [J]. Hepatol Int. 2023;17(4):927–941

Article  PubMed  Google Scholar 

Fridlender ZG, Sun J, Kim S, Kapoor V, Cheng G, Ling L, et al. Polarization of tumor-associated neutrophil phenotype by TGF-beta: “N1” versus “N2” TAN [J]. Cancer Cell. 2009;16(3):183–194

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cui C, Chakraborty K, Tang XA, Zhou G, Schoenfelt KQ, Becker KM, et al. Neutrophil elastase selectively kills cancer cells and attenuates tumorigenesis [J]. Cell. 2021;184(12):3163–77.e21

Article  CAS  PubMed  PubMed Central  Google Scholar 

Adrover JM, McDowell SAC, He XY, Quail DF, Egeblad M. NETworking with cancer: The bidirectional interplay between cancer and neutrophil extracellular traps [J]. Cancer Cell. 2023;41(3):505–526

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schoeps B, Eckfeld C, Prokopchuk O, Bottcher J, Haussler D, Steiger K, et al. TIMP1 Triggers Neutrophil Extracellular Trap Formation in Pancreatic Cancer [J]. Cancer Res. 2021;81(13):3568–3579

Article  CAS  PubMed  Google Scholar